McDermott Michael
SEC CIK 1902464 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PFE | Pfizer | EVP | 74.3K | — | — | 17 | 2022-02-23 | 2026-02-25 |
Most active insiders at PFE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | BOURLA ALBERT | COB, CEO, Dir | $1.00M | — |
| 2 | BLAYLOCK RONALD E | Dir | $998.8K | — |
| 3 | Buckley Mortimer J | Dir | $960.4K | — |
| 4 | DAMICO JENNIFER B. | SVP, Ctrl | — | $134.7K |
| 5 | BOSHOFF CHRISTOFFEL | Pres, R, D | — | — |
| 6 | McDermott Michael | EVP | — | — |
| 7 | SAHNI PAYAL | EVP | — | — |
| 8 | LANKLER DOUGLAS M | EVP | — | — |
| 9 | Fonseca Lidia | EVP | — | — |
Transactions 17
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-02-27 | 2026-02-25+ | PFE | Pfizer | McDermott Michael | EVP | F - Tax | $26.94 | -40.2K | 74.3K | -35% | -$1.08M |
| D | 2026-02-27 | 2026-02-25 | PFE | Pfizer | McDermott Michael | EVP | M - OptEx | $33.82 | +37.9K | 114.5K | +50% | +$1.28M |
| D | 2025-03-03 | 2025-02-27 | PFE | Pfizer | McDermott Michael | EVP | M - OptEx | $31.31 | +48.4K | 122.4K | +65% | +$1.52M |
| DM | 2025-03-03 | 2025-02-27 | PFE | Pfizer | McDermott Michael | EVP | F - Tax | $26.06 | -46.5K | 76.0K | -38% | -$1.21M |
| 2025-02-28 | 2025-02-26 | PFE | Pfizer | McDermott Michael | EVP | F - Tax | $26.42 | -3,220 | 74.0K | -4% | -$85.1K | |
| DM | 2025-02-25 | 2025-02-22 | PFE | Pfizer | McDermott Michael | EVP | F - Tax | $26.09 | -10.4K | 77.2K | -12% | -$271.9K |
| D | 2025-02-25 | 2025-02-22 | PFE | Pfizer | McDermott Michael | EVP | M - OptEx | $30.17 | +11.1K | 87.6K | +15% | +$335.6K |
| DM | 2024-02-27 | 2024-02-23+ | PFE | Pfizer | McDermott Michael | EVP | F - Tax | $27.39 | -19.9K | 94.5K | -17% | -$546.2K |
| D | 2024-02-27 | 2024-02-23 | PFE | Pfizer | McDermott Michael | EVP | M - OptEx | $27.34 | +12.4K | 95.4K | +15% | +$339.3K |
| DM | 2023-02-28 | 2023-02-25+ | PFE | Pfizer | McDermott Michael | EVP | F - Tax | $42.38 | -12.2K | 84.0K | -13% | -$518.1K |
| D | 2023-02-28 | 2023-02-25 | PFE | Pfizer | McDermott Michael | EVP | M - OptEx | $22.89 | +14.2K | 93.1K | +18% | +$324.5K |
| DM | 2023-02-24 | 2023-02-22 | PFE | Pfizer | McDermott Michael | EVP | F - Tax | $43.45 | -10.0K | 78.9K | -11% | -$436.0K |
| D | 2023-02-24 | 2023-02-22 | PFE | Pfizer | McDermott Michael | EVP | M - OptEx | $30.17 | +13.3K | 89.0K | +18% | +$401.5K |
| D | 2022-03-01 | 2022-02-26 | PFE | Pfizer | McDermott Michael | EVP | M - OptEx | $25.60 | +12.3K | 83.5K | +17% | +$315.9K |
| DM | 2022-03-01 | 2022-02-26+ | PFE | Pfizer | McDermott Michael | EVP | F - Tax | $49.37 | -9,517 | 81.2K | -10% | -$469.9K |
| D | 2022-02-25 | 2022-02-23 | PFE | Pfizer | McDermott Michael | EVP | M - OptEx | $27.34 | +15.0K | 81.5K | +22% | +$408.8K |
| DM | 2022-02-25 | 2022-02-23 | PFE | Pfizer | McDermott Michael | EVP | F - Tax | $50.03 | -10.3K | 78.6K | -12% | -$516.7K |
Purchase Sale Sale after option exercise All abbreviations